Introduction
============

Universal accessibility and the use of antiretroviral therapy (ART) has changed the fate of HIV-positive patients from life-threatening to a chronic condition by suppressing the viral load and restoring the immune system.[@b1-hiv-11-009] In 2016, \~36.7 million people were living with HIV, and about 1 million died of HIV-related illness.[@b1-hiv-11-009] However, adverse drug reactions (ADRs) to these medications remained as an important reason of concern that may compromise the effectiveness of the ART programs.[@b2-hiv-11-009]

A high number of ADRs related to ART, such as skin rash, anemia, nausea, diarrhea, peripheral neuropathy, and much more, were documented across the world.[@b3-hiv-11-009]--[@b6-hiv-11-009] Patient-reported ADRs may differ between developing and developed countries[@b7-hiv-11-009],[@b8-hiv-11-009] and the incidence of ADRs were more likely to happen in ART-naive patients.[@b9-hiv-11-009]--[@b12-hiv-11-009] Reporting of ADRs during monthly visits to ART clinics provides important implications for switching the medications and minimizing the potential threats. In fact, ADR reporting does not seem simple in ART-naïve patients unless having some knowledge about the type of ADRs experience during ART initiation.[@b11-hiv-11-009]

In health communication, pictogram has a comprehensive place to aid attention, memory recall, and promote adherence to medications. Several health-based pictorial intervention studies demonstrated the benefits of these tools to make patients better understand medical instructions and warnings.[@b13-hiv-11-009]--[@b16-hiv-11-009] Pictograms can help increase patients' knowledge, especially of those who have insufficient knowledge, particularly in countries with low rates of illiteracy.[@b17-hiv-11-009],[@b18-hiv-11-009] In many countries, pictogram-based intervention is considered to be very limited, and it was applied notably to improve patients' knowledge of medicine information.[@b19-hiv-11-009]--[@b21-hiv-11-009] However, Dowse et al have taken the initiative to develop a validated tool to communicate ART side effects to low-literacy HIV population in South Africa.[@b22-hiv-11-009] The interpretation of these visual images produced was accepted among HIV patients with low literacy. A pictogram-based intervention has been developed to identify and improve ADR reporting among ART-naïve patients with low literacy and having insufficient health information knowledge. Therefore, this study aimed to assess whether a pictogram-based intervention would help to identify and improve ADR reporting in an ART clinic serving HIV patients in Northwest Ethiopia.

Patients and methods
====================

Study setting and population
----------------------------

A cross-sectional study was conducted among ART-naïve patients registered for treatment at ART clinic, Gondar University Hospital (GUH), Northwest Ethiopia. GUH is a 550-bed comprehensive, specialized teaching hospital serving as a referral center for a population of \~7 million people living in and around Gondar.

Adult (\>18 years of age) HIV-positive patients who were newly registered (no longer than 6 months) for first-line ART treatment, visiting GUH for refilling their prescription and were willing to provide written informed consent were included. Hospitalized, severely sick, and patients who were unable to understand the purpose of the study or provide informed consent were excluded.

Survey instrument and content
-----------------------------

A self-administered questionnaire compromising three sections was developed based on a literature review[@b18-hiv-11-009]--[@b24-hiv-11-009] and the research experience of the investigators. To better understand the effect of pictorial representation, two types of questionnaires were developed. Pictorial questionnaire for group A and non-pictorial questionnaire for group B. The content of these questionnaires are quite similar except patients randomized in group A were given pictorial representation to identify their own ART drugs and dosages, and different ADRs.

The questionnaire developed for the two groups, A and B, comprised of three sections. Section 1 includes sociode-mographic details (nine items), current comorbidities (one item), and other medical information, such as CD4 cell count, medication history, history of hospitalization, enrollment in ready-to-use therapeutic food program, and information related to discomfort with ART medication. Open-ended questions were used to obtain their responses. Section 2 covers the type of ART medications used and the dosage information. Section 3 includes a list of different ADRs encountered while using ART medications, reported for the last month. For sections 2 and 3, empty spaces were provided to mark them as identified.

Questionnaire validation and reliability
----------------------------------------

The developed instrument was translated from English to Amharic (back and forward method), which was done by distributing the questionnaire to six expert faculty members. The Amharic version was used for the study participants. The developed questionnaires (groups A and B) were tested for reliability, psychometric, and internal validation. The internal consistency estimate of the reliability of test scores (Cronbach's alpha) was found to be 0.87 (pictorial) and 0.92 (control), indicating a good construct of the tool. The questionnaires were pilot tested among 20 volunteer patients and 10 senior academicians to assess the content validity. The feedback provided was used to make minor modifications to the questionnaires. The results of the piloting phase were not included. The questionnaire was completed in the waiting room or at the pharmacy refilling room and took an average of 20 minutes to complete. Study investigators (EAG, TMA, TBA, SAB, and HGT) participated in collecting and retrieving the information on a daily basis during the study period.

Study design
------------

The study was conducted from July 2015 to January 2016. The patients were randomly categorized into two groups based on their ART unique identification number. A total of 234 participants were identified during the study period and randomized into group A (117), and group B (117) using concealment published randomization technique.[@b25-hiv-11-009] Participants in group A were subjected to receive pictorial medication information and a pictogram-enhanced tool to identify and report ADRs, while those in group B did not receive any pictogram-enhanced tool to identify the medications and report ADRs. Both groups received standard care.

Outcome measures
----------------

The primary outcome was to check if there is difference between groups A and B in identifying ART medications, and identifying and reporting ADRs. The secondary outcome was to check if there is any association between sociodemo-graphic characteristics of patients, and identification and reporting of ADRs.

Ethical considerations
----------------------

Ethical clearance was obtained from the institutional ethical committee of the University of Gondar-School of Pharmacy. Written informed consent was also obtained from each participant before participating in the study. Confidentiality of participants' personal information was maintained throughout the study. The study was conducted in accordance with the Declaration of Helsinki.

Statistical analysis
--------------------

All the statistical data were carried out using SPSS, version 22 (IBM Corporation, Armonk, NY, USA). Descriptive statistics are presented using frequencies and percentages (%). Bivariate analysis was conducted to identify associations between sociodemographic factors and ADR identification and reporting by the study participants. OR with 95% CI was used to measure the magnitude and statistical significance of the association. Binary logistic regression was performed to detect differences in the identification of ART medications and reporting ADRs between the two groups. The association was then expressed as OR (95% CI) and *P*-value. *P*\<0.05 was considered significant.

Results
=======

Of the 234 patients (117 in either group), 27 were excluded from the final analyses either because they did not give consent to participate (n=20) or returned incomplete questionnaires (n=7), giving a response rate of 88.5%. A total of 207 ART-naïve HIV-positive patients registered for the ART treatment attending GUH ART clinic were included. Participants were randomized into group A (n=113) and group B (n=94). In the study population, males were slightly higher in number than females (51.2% vs 48.8%), with a mean age of 35.15 (SD ±10.28) years. Majority of participants (75%) reported receiving a different level of education while the remaining were unable to read or write. Majority of the participants were orthodox Christians (87.92%), unemployed (66.18%), and with no sources of income (73.43%). The mean CD4 cell count was 426 (SD ±178.12). The sociodemographic characteristics are presented in [Table 1](#t1-hiv-11-009){ref-type="table"}. There was no statistically significant difference between the two groups (*P*\>0.05). Compared with group B, the most common comorbid condition noticed in group A was community-acquired pneumonia (n=14 vs n=16), followed by fever/diarrhea (n=6 vs n=8), pulmonary tuberculosis (n=11 vs n=7), and others (n=20 vs n=17) ([Table 1](#t1-hiv-11-009){ref-type="table"}).

Bivariate analysis of sociodemographic characteristics, such as age, sex, education, employment, and marital status identified sex as the only predictor of identifying and reporting ADRs. Males were twice more likely to identify ADRs than females ([Table 2](#t2-hiv-11-009){ref-type="table"}).

Of the ART medication regimens, the zidovudine (AZT)/lamivudine (3TC)/nevirapine (NVP) (n=44) and tenofovir (TDF)/lamivudine/efavirenz (EFV) (n=38) were the most frequently prescribed medications in both groups A and B (n=29 and n=32) ([Figure 1](#f1-hiv-11-009){ref-type="fig"}).

Four different ART regiments were used by the patients. These include the following: AZT-3TC-NVP (n=73, 35.3%), AZT-3TC-EFV (n=16, 7.7%), TDF-3TC-EFV (n=70, 33.8%), and TDF-3TC-NVP (n=48, 23.2%). AZT-3TC-NVP and TDF-3TC-EFV were available as single pills. On the other hand, patients taking either TDF-3TC-NVP or AZT-3TC-EFV were taking two pills (AZT-3TC single pill plus EFV or TDF-3TC plus NVP). Univariate analysis revealed that participants in group A showed a statistically significant association with the ability to identify ART medications using pictograms. Group A participants were more likely to identify 3TC (OR \[95% CI\] =7.536 \[4.042--14.021\], *P*≤0.001), TDF (OR \[95% CI\] =6.250 \[2.855--13.682\], *P*≤0.001), NVP (OR \[95% CI\] =5.320 \[1.954--14.484\], *P*=0.001), EFV (OR \[95% CI\] =3.929 \[1.876--8.228\], *P*≤0.001), and AZT (OR \[95% CI\] =3.570 \[1.602--7.960\], *P*=0.002) using pictograms. Compared with group B, group A was 4.3 times more likely to identify diarrhea as an ADR by using pictogram. However, no significant association was identified for other ADRs between the groups ([Table 3](#t3-hiv-11-009){ref-type="table"}).

Discussion
==========

Although ADRs to ART medications in HIV-positive patients are well known, there has been limited focus on identification and reporting errors made by patients with low literacy. The results of this study have highlighted the fact that a pictorial representation slightly improved the identification and report ing of ADRs among ART-naïve patients. Other effects were also observed, including identification of dosing frequency of ART medications and improved ADR reporting. This intervention in a resource-limited setting and considerable reduction of risks, support its potential utility in clinical practice.

Aspects related to research methods support the validity of the results in the present study. For instance, this study utilized validated information materials from another study[@b22-hiv-11-009] that facilitated recall of medicine-related information to culturally and linguistically diverse Ethiopian HIV/AIDS patients with limited literacy skills, which yielded consistent findings. Also, this tool can be used both by patients to report ADRs efficiently and by health care providers as an aid to improve communication, counseling and illustrate HIV-treatment ADRs. It was noted that there are no such tools for assessing ADRs to medications using pictures. However, further investigation with improved research designs such as randomized controlled trials would be of benefit.

The findings of this study are consistent with existing data regarding the use of pictorial illustration and medication-related instructions.[@b13-hiv-11-009],[@b22-hiv-11-009]--[@b24-hiv-11-009],[@b26-hiv-11-009],[@b27-hiv-11-009] Pictograms have been found to reinforce and draw attention, particularly for patients with low literacy.[@b28-hiv-11-009]--[@b30-hiv-11-009] Few studies have assessed pictogram intervention in ART patients.[@b13-hiv-11-009],[@b19-hiv-11-009],[@b20-hiv-11-009] One study showed that pictograms are well understood in low-literacy ART settings. The overall ability to identify the ART medications (all first-line medications included) was significantly higher in group A (34.2% vs 11.8%). However, most of the ADRs lacked statistical signifi-cance, higher number of ADRs were identified and reported from the group A (43 vs 19). Most frequently reported ADRs were nausea and vomiting (18 vs 8), and diarrhea (14 vs 4).

Moreover, the pictograms for myalgia, depression, and headache were not identified by group A. This shows that common ADRs experienced by the ART patients are very well reported, and this shows the importance of further investigation of pictogram as a readily interpretable tool to convey a health-related message.

This pictogram has broad applicability for communication and education of patients. Medication ADRs are often not adequately discussed with patients. Hence, these ADRs information can be included along with the written ART medication leaflets only after the pharmacist has counseled the patients, particularly to low-literacy patients. Pictogram could also be used by a pharmacist to educate about ADRs associated with ART and also can aid to support group patient education sessions. Adequate medication-related counseling can help to increase the awareness about possible ADRs and could improve adherence to ART medications.

The study has some limitations. First, the pictorial representation in ART-naïve registered patients attending GUH was randomly evaluated, and the results may differ for follow-up assessment. Furthermore, these pictograms were assessed quantitatively in ART patient, and the causality assessment scales were not used to confirm the reported ADRs. We relied on the participants' honesty while reporting ADRs, hence the participants may over-report or under-report to socially desirable answers that may lead to response bias. The study was conducted in a single center, and most of the participants were from low to middle socioeconomic class, which limits its statistical generalizability and so does not reflect all HIV-positive patients in Ethiopia. It is, therefore, difficult to extrapolate the results to other countries and people living in other settings. Finally, the majority of the participants who received the questionnaire may or may not have experienced ADRs, and this may have possibly skewed the results to look as though there are no significant differences between the two groups.

Conclusion
==========

The use of pictorial representation resulted in only slight improvement in identification and reporting of ADRs among naïve HIV-positive patients with limited literacy in Northwest Ethiopia. This representation of ADRs provided an insight with the potential implications to identification of ART medications but merits from further investigation with better study designs and larger sample sizes that focus on HIV-positive patients with limited educational levels.
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###### 

Characteristics of study population

  Characteristics                                  Group A, n=113 (%)   Group B, n=94 (%)   Total,N=207 (%)
  ------------------------------------------------ -------------------- ------------------- -----------------
  Age (years)                                                                               
  18--29                                           27 (23.9)            30 (31.9)           57 (27.5)
  30--39                                           43 (38.1)            37 (39.4)           80 (38.6)
  40--49                                           29 (25.7)            21 (22.3)           50 (24.2)
  ≥50                                              14 (12.4)            6 (6.4)             20 (9.7)
  Sex                                                                                       
  Female                                           57 (50.4)            44 (46.8)           101 (48.8)
  Male                                             56 (49.6)            50 (53.2)           106 (51.2)
  Education                                                                                 
  Unable to read or write                          25 (22.1)            25 (26.6)           50 (24.2)
  Primary school                                   51 (45.1)            34 (36.2)           85 (41.1)
  Secondary school                                 32 (28.3)            29 (30.9)           61 (29.5)
  College and above                                5 (4.4)              6 (6.4)             11 (5.3)
  Employment                                                                                
  Unemployed                                       74 (65.5)            63 (67.0)           137 (66.2)
  Employed                                         34 (30.1)            27 (28.7)           61 (29.5)
  Student                                          5 (4.4)              4 (4.3)             9 (4.3)
  Marital status                                                                            
  Single                                           45 (39.8)            37 (39.4)           82 (39.6)
  Married                                          49 (43.4)            41 (43.6)           90 (43.5)
  Widowed                                          7 (6.2)              2 (2.1)             9 (4.3)
  Divorced                                         8 (7.1)              10 (10.6)           18 (8.7)
  Separated                                        4 (3.5)              4 (4.3)             8 (3.9)
  Religion                                                                                  
  Orthodox Christian                               98 (86.7)            84 (89.4)           182 (87.9)
  Protestant                                       1 (0.9)              0 (0.0)             1 (0.5)
  Muslim                                           13 (11.5)            9 (9.6)             22 (10.6)
  Others                                           1 (0.9)              1 (1.1)             2 (1.0)
  Number of family members with HIV                                                         
  None                                             40 (35.4)            39 (41.5)           79 (38.2)
  One                                              38 (33.6)            24 (25.5)           62 (30.0)
  Two                                              30 (26.5)            24 (25.5)           54 (26.1)
  Three                                            5 (4.4)              7 (7.4)             12 (5.8)
  Average monthly family income (Ethiopian Birr)                                            
  No income                                        82 (72.6)            70 (74.5)           152 (73.4)
  100--200                                         --                   4 (4.3)             4 (1.9)
  201--500                                         4 (3.5)              5 (5.3)             9 (4.3)
  501--1,000                                       15 (13.3)            9 (9.6)             24 (11.6)
  \>1,000                                          12 (10.6)            6 (6.4)             18 (8.7)
  Current CD4 cell count                                                                    
  Median                                           390                  420                 399
  \<350                                            42 (37.2)            34 (36.2)           76 (36.7)
  ≥350                                             71 (62.8)            60 (63.8)           131 (63.3)
  Comorbid conditions                                                                       
  Community-acquired pneumonia                     14 (12.4)            16 (17.0)           30 (14.5)
  Pulmonary tuberculosis                           11 (9.7)             7 (7.4)             18 (8.7)
  Fever/diarrhea \>1 month                         6 (5.3)              8 (8.5)             14 (6.8)
  Oropharyngeal candidiasis                        6 (5.3)              4 (4.3)             10 (4.8)
  Wasting syndrome                                 4 (3.5)              5 (5.3)             9 (4.3)
  Gastrointestinal symptoms                        3 (2.7)              3 (3.2)             6 (2.9)
  Extrapulmonary tuberculosis                      4 (3.5)              2 (2.1)             6 (2.9)
  Others                                           20 (17.7)            17 (18.1)           37 (17.9)

###### 

Bivariate associations of sociodemographic factors with identifying and reporting ADRs

                            ADRs                    
  ------------------------- ----------- ----------- ----------------------
  Age (years)                                       
  18--29                    19 (33.3)   38 (66.7)   1
  30--39                    17 (21.2)   63 (78.8)   1.5 (0.474--4.748)
  40--49                    21 (42)     29 (58)     0.81 (0.258--2.544)
  50 and above              5 (25)      15 (75)     2.172 (0.683--6.912)
  Sex                                               
  Female                    23 (22.8)   78 (77.2)   1
  Male                      39 (36.8)   67 (63.2)   1.974 (1.073--3.633)
  Education                                         
  Unable to read or write   15 (30)     35 (70)     1
  Primary school            30 (35.3)   55 (64.7)   1.273 (0.601--2.697)
  Secondary school          14 (23)     47 (77)     0.695 (0.297--1.626)
  College and above         3 (27.3)    8 (72.7)    0.875 (0.204--3.761)
  Employment                                        
  Unemployed                38 (27.7)   99 (72.3)   1
  Employed                  23 (37.7)   38 (62.3)   1.577 (0.833--2.987)
  Student                   1 (11.1)    8 (88.9)    0.326 (0.039--2.692)
  Marital status                                    
  Single                    27 (32.9)   55 (67.1)   1
  Married                   26 (28.9)   64 (77.1)   0.828 (0.433--1.582)
  Widowed                   3 (33.3)    6 (66.7)    1.019 (0.236--4.388)
  Divorced                  4 (22.2)    14 (77.8)   0.582 (0.175--1.938)
  Separated                 2 (25)      6 (75)      0.679 (0.128--3.59)

**Note:** Values in bold font are statistically significant.

**Abbreviation:** ADRs, adverse drug reactions.

###### 

Univariate associations of the identification of ART medications and reporting ADRs among the study population

  Identification of ART medications and ADRs N (%)   Group A, n=113 N (%)   Group B, n=94 N (%)   OR (95% CI)             *P*-value
  -------------------------------------------------- ---------------------- --------------------- ----------------------- -----------
  Identified ART medications                                                                                              
  Lamivudine                                         89 (78.8)              31 (33.0)             7.536 (4.042--14.021)   0.000
  Zidovudine                                         31 (27.4)              9 (9.6)               3.570 (1.602--7.960)    0.002
  Efavirenz                                          39 (11.8)              11 (34.5)             3.929 (1.876--8.228)    0.000
  Nevirapine                                         26 (23.0)              5 (5.3)               5.320 (1.954--14.484)   0.001
  Tenofovir                                          7 (6.2)                3 (3.2)               6.250 (2.855--13.682)   0.000
  Identified ADRs                                                                                                         
  None                                               80 (70.8)              65 (69.1)                                     1
  Nausea                                             9 (8.0)                4 (4.3)               0.547 (0.161--1.857)    0.333
  Vomiting 1--2 times a month                        9 (8.0)                4 (4.3)               0.547 (0.161--1.857)    0.333
  Diarrhea                                           14 (12.4)              4 (4.3)               4.308 (1.353--14.719)   0.013
  Others                                             11 (9.7)               7 (7.4)               0.753 (0.287--2.134)    0.633

**Note:** Values in bold font are statistically significant.

**Abbreviations:** ADRs, adverse drug reactions: ART, antiretroviral.
